FLT3 and acute myeloid leukemia: For example, in the UK NCRI AML19 trial (n = 1705), 70% of patients with FLT3 mutated AML (n = 481) had a co-occurring NPM1mut or FG (unpublished data, Supplementary Fig. 1).